| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3328969 | Critical Reviews in Oncology/Hematology | 2012 | 5 Pages |
Abstract
Post-mastectomy RT decreases the rate of locoregional recurrences of about 70% in all patients irrespective of age, tumor characteristics or systemic therapy. Post-mastectomy RT has to be proposed, moreover when locoregional lymph nodes are part of the PTV, if an optimal coverage of the PTV and a satisfactory sparing of the OAR could be obtained. Due to the results of meta-analysis, consensus conferences and randomized trials the long-term efficacy of RT in decreasing the risk of LRF is well established and the vast majority of women, treated with mastectomy, will benefit from it.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Maria Carla Valli,